The Intravenous Immunoglobulin Market report through its overview section
provides the overall scenario and dynamics of the global Intravenous Immunoglobulin Market with its definition and other details. Further, the key player and competitive landscape segment of the report enlist the various players actively participating and competing in the global market. The report also entails the new market entrants. The key major market players include
LFB Biotechnologies, Biotest, Octapharma, Grifols, CSL Behring, China Biologics Products, Kedrion Biopharma, BDI Pharma, Shire The report encompasses the leading manufacturers along with their respective share in the global market in terms of revenue. Moreover, it mentions their tactical steps in the last few years, leadership changes, and product innovation investments to help in making well-informed decisions and also to stay at the forefront in the competition.
Search jobs 15-Dec-2020
Global Immunoglobulin Market – Insights
An immunoglobulin (IG), also known as an antibody, is a protein produced mainly by plasma cells. The immune system uses IGs to neutralize pathogens such as pathogenic bacteria and viruses. The immune response of IG is highly complex and very specific. There are different types of IGs that differ in their biological features, structure, target specificity, and distribution such as IgG, IgA, and IgM. These IGs can be administered intravenously and subcutaneously for the treatment of various immunological and neurological diseases such as multiple sclerosis, Primary Humoral Immunodeficiency (PIDD), Immune Thrombocytopenia Purpura (ITP), and autoimmune haemolytic anemia. IG also finds application in the field of hematology, neurology, immunology, dermatology, ophthalmology, nephrology and rheumatology. Assessment of the IG isotype can offer valuable perspective regarding complex humoral immune re